InflaRx (IFRX) Assets (2016 - 2026)
InflaRx's (IFRX) quarterly Assets came in at $194.0 million in Q2 2026, up 133.37% year-over-year from $83.1 million in Q2 2025, and up 238.95% quarter-over-quarter from $57.2 million in Q1 2026.
Analysis
InflaRx (IFRX) Assets (2016 - 2026) Analysis & Trends
InflaRx has disclosed Assets across 11 years of filings, most recently posting $194.0 million for Q2 2026.
- In Q2 2026, Assets rose 133.37% year-over-year to $194.0 million; the TTM figure through Jun 2026 stood at $194.0 million (up 133.37% YoY), while the FY2025 annual figure was $62.4 million, down 23.2% from the prior year.
- Assets came in at $194.0 million for Q2 2026 at InflaRx, up from $57.2 million in the prior quarter.
- In the past five years, Assets ranged from a high of $194.0 million in Q2 2026 to a low of $57.2 million in Q1 2026.
- Average Assets over 5 years is $107.1 million, with a median of $102.3 million recorded in 2022.
- Year-over-year, Assets plunged 37.91% in 2024 and jumped 133.37% in 2026.
- Over 5 years, Assets stood at $104.5 million in 2022, then rose by 23.8% to $129.3 million in 2023, then tumbled by 37.19% to $81.2 million in 2024, then declined by 20.88% to $64.3 million in 2025, then jumped by 201.84% to $194.0 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $194.0 million in Q2 2026, $57.2 million in Q1 2026, and $64.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 194.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194.01 Mn |
| Mar 31, 2026 | 57.24 Mn |
| Dec 31, 2025 | 64.27 Mn |
| Sep 30, 2025 | 76.17 Mn |
| Jun 30, 2025 | 83.13 Mn |
| Mar 31, 2025 | 91.51 Mn |
| Dec 31, 2024 | 81.23 Mn |
| Sep 30, 2024 | 87.51 Mn |
| Jun 30, 2024 | 100.19 Mn |
| Mar 31, 2024 | 116.34 Mn |
| Dec 31, 2023 | 129.34 Mn |
| Sep 30, 2023 | 140.96 Mn |
| Jun 30, 2023 | 144.79 Mn |
| Mar 31, 2023 | 92.64 Mn |
| Dec 31, 2022 | 104.47 Mn |
| Sep 30, 2022 | 112.04 Mn |
| Jun 30, 2022 | 122.32 Mn |
| Mar 31, 2022 | 129.16 Mn |
| Dec 31, 2021 | 143.16 Mn |
| Sep 30, 2021 | 152.57 Mn |